CIK 0001870404 · <br>Emerging growth company
CERO THERAPEUTICS HOLDINGS, INC.
Sign in to watch- Tickers
- CERO CEROW
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 871088814
- Phone
- 650-407-2376
- Business address
- 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CERO THERAPEUTICS HOLDINGS, INC., PHOENIX BIOTECH ACQUISITION CORP.
Securities
- CERO Common stock OTC
- CEROW Common stock OTC
- 424B3 Offering Prospectus
- 8-K Event Unregistered share sale · Other events
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 5,957,250 shares at an average $0.07 ($400,456)
- 4 Open-market sale 10% owner sold 3,658,364 shares at an average $0.10 ($383,370)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Other events
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 23 · 445 filings